NCT03555942View on ClinicalTrials.gov

Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

December 1, 2021

Conditions
Infertility
Interventions
DRUG

Follicular phase corifollitropin alfa

GnRH antagonist protocol with corifollitropin alfa initiated in the follicular phase (day 2 or 3 of the menstrual cycle)

DRUG

Luteal phase corifollitropin alfa

GnRH antagonist protocol with corifollitropin alfa initiated in the luteal phase (5 days after an LH peak)

Trial Locations (2)

08028

Consultorio Dexeus, Barcelona

08037

Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus, Barcelona

All Listed Sponsors
lead

Fundacion Dexeus

OTHER

NCT03555942 - Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa | Biotech Hunter | Biotech Hunter